Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126676603 | 12667660 | 3 | F | 20151031 | 20160830 | 20160819 | 20160909 | EXP | IT-PFIZER INC-2016379173 | PFIZER | 45.00 | YR | M | Y | 65.00000 | KG | 20160909 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126676603 | 12667660 | 1 | SS | DACOMITINIB | DACOMITINIB | 1 | Oral | 30 MG, CYCLIC (30 MG DAILY C1D1) | Y | 14-00341 | 0 | 30 | MG | TABLET | |||||
| 126676603 | 12667660 | 2 | PS | RAPAMUNE | SIROLIMUS | 1 | 2 MG/1 MG EVERY OTHER DAY | Y | 21110 | QOD | |||||||||
| 126676603 | 12667660 | 3 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | BID | ||||||||
| 126676603 | 12667660 | 4 | C | SEACOR | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 126676603 | 12667660 | 5 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 126676603 | 12667660 | 6 | C | FUCICORT | BETAMETHASONE VALERATEFUSIDIC ACID | 1 | UNK | 0 | OINTMENT | ||||||||||
| 126676603 | 12667660 | 7 | C | URBASON /00049601/ | METHYLPREDNISOLONE | 1 | 4 MG, DAILY | 0 | 4 | MG | |||||||||
| 126676603 | 12667660 | 8 | C | ARANESP | DARBEPOETIN ALFA | 1 | UNK, EVERY 3 WEEKS | 0 | Q3W | ||||||||||
| 126676603 | 12667660 | 9 | C | ZYLORIC | ALLOPURINOL | 1 | 300 MG, ALTERNATE DAY | 0 | 300 | MG | QOD | ||||||||
| 126676603 | 12667660 | 10 | C | SELEPARINA | NADROPARIN CALCIUM | 1 | Subcutaneous | 0.6 IU, UNK | 0 | .6 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126676603 | 12667660 | 1 | Squamous cell carcinoma of skin |
| 126676603 | 12667660 | 2 | Immunosuppression |
| 126676603 | 12667660 | 7 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126676603 | 12667660 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126676603 | 12667660 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126676603 | 12667660 | 1 | 20151013 | 20151030 | 0 | |
| 126676603 | 12667660 | 2 | 2002 | 20151031 | 0 | |
| 126676603 | 12667660 | 7 | 2002 | 0 |